Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

Effect of Individually Trained Oral Prophylaxis (iTOP) on Gingival Health in Orthodontic Patients

Study ID: NCT07468773
Start Date: 2026-03-30
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Individually Trained Oral Prophylaxis (iTOP) Oral Hygiene Training

Conventional Oral Hygiene Instruction

Sponsor

Gulf Medical University

Source: clinicaltrials.gov

Share:
Add to list

Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus

Study ID: NCT06488469
Start Date: 2026-07-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Psychological Interventions for children and adolescents

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

Study ID: NCT07416526
Start Date: 2026-05-09
End Date: 2031-09-23
Study Type

Interventional

Study Phase

Phase3

No. of Participants

126

Intervention / Treatment

NXT007

Human Coagulation Factor VIII

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA

Study ID: NCT06474325
Start Date: 2026-06-01
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Intervention via mobile application

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Study ID: NCT07459751
Start Date: 2026-04-09
End Date: 2030-01-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

671

Intervention / Treatment

HLX43

HLX43+HLX07

Docetaxel

Sponsor

Shanghai Henlius Biotech

Source: clinicaltrials.gov

Share:
Add to list

Tolerability of Enteral NAC in Infants

Study ID: NCT06260566
Start Date: 2026-10
End Date: 2031-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

N-Acetylcysteine

Sponsor

Sanjeev Harpavat

Source: clinicaltrials.gov

Share:
Add to list

A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis

Study ID: NCT03468556
Start Date: 2026-04-01
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

SNP-610

Placebo Oral Tablet

Sponsor

Sinew Pharma Inc.

Source: clinicaltrials.gov

Share:
Add to list

Argus 2.0 Adoption Study

Study ID: NCT07425236
Start Date: 2026-04-19
End Date: 2027-08-19
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

KOS Argus Continuous Glucose Monitoring System

Sponsor

KOS Inc.

Source: clinicaltrials.gov

Share:
Add to list

CPAP in Patients With Severe Obesity After Anesthesia

Study ID: NCT06287632
Start Date: 2026-06
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Recruitment/ITP-CPAP (Intervention A)

Standard CPAP (Intervention B)

Atmospheric Pressure

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

Study ID: NCT07178912
Start Date: 2026-08-27
End Date: 2033-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Blinatumomab

olverembatinib

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list